Grand Rounds Recap 04.21.21

/
Grand Rounds Recap 04.21.21

Extra! Extra! We had excellent content this week in Grand Rounds. Dr. Paulsen started us off with discussing the difference in generational and gender-based communication approaches in our quarterly Leadership Curriculum. Drs. Frankenfeld and Ijaz then expertly discussed their new status epilepticus algorithm in QI/KT. Dr. Hill discussed his passion for diltiazem use in A.fib with RVR in his attending case follow up. Dr. Martella educated us on the evidence behind the most common medications given for renal colic in the ED during his R1 Clinical Treatment. Lastly, Drs. Broadstock and Lang battled it out in CPC involving a case of thyroid storm.

Read More

Controversies in Kidney Stones

/
Controversies in Kidney Stones

Flank pain and pain due to ureterolithiasis are common ED presentations. There exist, however, a number of controversies when you dive into the literature addressing the diagnosis and treatment of nephrology/ureterolithiasis. Is IV lidocaine effective at treating pain in these patients? Is there a way to avoid CT scans? What about tamsulosin? Is it only good for big stones/small stones? Is there a benefit at all. For our most recent Journal Club, we tackled several of these controversies. Take a listen to the podcast below or over on iTunes.

Read More

Grand Rounds Recap 2.20.19

/
Grand Rounds Recap 2.20.19

This week’s grand rounds started with Dr. Colmer reviewing some fascinating cases in this months Morbidity and Mortality. We then split up into groups and did the quarterly sim focusing on informed consent led by Drs. LaFollette and Lang. This was followed by some challenging oral boards cases chosen by Drs. McDonough and Hill. Look forward to next week!

Read More

Grand Rounds Summary - July 29th, 2015

/
Grand Rounds Summary - July 29th, 2015

Morbidity and Mortality Pearls with Dr. Curry

Nephrolithiasis

Incidence in the US is 0.5-1% (lifetime risk 10-15%). There is a 2:1 male predominance and the recurrence rate is fairly high (37% at 1 year, 50% at 10 years and 75% at 20 years).

Patients at risk for poorer outcomes with ureterolithiasis are those with risk factors for diminished renal function, history of difficulty with stones/urologic intervention and symptoms of infection.

Read More